Literature DB >> 19834014

Significance of large vessel intracranial occlusion causing acute ischemic stroke and TIA.

Wade S Smith1, Michael H Lev, Joey D English, Erica C Camargo, Maggie Chou, S Claiborne Johnston, Gilberto Gonzalez, Pamela W Schaefer, William P Dillon, Walter J Koroshetz, Karen L Furie.   

Abstract

BACKGROUND AND
PURPOSE: Acute ischemic stroke due to large vessel occlusion (LVO)-vertebral, basilar, carotid terminus, middle and anterior cerebral arteries-likely portends a worse prognosis than stroke unassociated with LVO. Because little prospective angiographic data have been reported on a cohort of unselected patients with stroke and with transient ischemic attack, the clinical impact of LVO has been difficult to quantify.
METHODS: The Screening Technology and Outcome Project in Stroke Study is a prospective imaging-based study of stroke outcomes performed at 2 academic medical centers. Patients with suspected acute stroke who presented within 24 hours of symptom onset and who underwent multimodality CT/CT angiography were approached for consent for collection of clinical data and 6-month assessment of outcome. Demographic and clinical variables and 6-month modified Rankin Scale scores were collected and combined with blinded interpretation of the CT angiography data. The OR of each variable, including occlusion of intracranial vascular segment in predicting good outcome and 6-month mortality, was calculated using univariate and multivariate logistic regression.
RESULTS: Over a 33-month period, 735 patients with suspected stroke were enrolled. Of these, 578 were adjudicated as stroke and 97 as transient ischemic attack. Among patients with stroke, 267 (46%) had LVO accounting for the stroke and 13 (13%) of patients with transient ischemic attack had LVO accounting for transient ischemic attack symptoms. LVO predicted 6-month mortality (OR, 4.5; 95% CI, 2.7 to 7.3; P<0.001). Six-month good outcome (modified Rankin Scale score <or=2) was negatively predicted by LVO (0.33; 0.24 to 0.45; P<0.001). Based on multivariate analysis, the presence of basilar and internal carotid terminus occlusions, in addition to National Institutes of Health Stroke Scale and age, independently predicted outcome.
CONCLUSIONS: Large vessel intracranial occlusion accounted for nearly half of acute ischemic strokes in unselected patients presenting to academic medical centers. In addition to age and baseline stroke severity, occlusion of either the basilar or internal carotid terminus segment is an independent predictor of outcome at 6 months.

Entities:  

Mesh:

Year:  2009        PMID: 19834014      PMCID: PMC2796543          DOI: 10.1161/STROKEAHA.109.561787

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  16 in total

1.  Intra-arterial prourokinase for acute ischemic stroke. The PROACT II study: a randomized controlled trial. Prolyse in Acute Cerebral Thromboembolism.

Authors:  A Furlan; R Higashida; L Wechsler; M Gent; H Rowley; C Kase; M Pessin; A Ahuja; F Callahan; W M Clark; F Silver; F Rivera
Journal:  JAMA       Date:  1999-12-01       Impact factor: 56.272

2.  NIHSS score and arteriographic findings in acute ischemic stroke.

Authors:  Urs Fischer; Marcel Arnold; Krassen Nedeltchev; Caspar Brekenfeld; Pietro Ballinari; Luca Remonda; Gerhard Schroth; Heinrich P Mattle
Journal:  Stroke       Date:  2005-09-08       Impact factor: 7.914

Review 3.  Intra-arterial thrombolytic therapy for acute basilar occlusion: pro.

Authors:  Wade S Smith
Journal:  Stroke       Date:  2007-02       Impact factor: 7.914

4.  Predicting outcome after acute and subacute stroke: development and validation of new prognostic models.

Authors:  Carl Counsell; Martin Dennis; Michael McDowall; Charles Warlow
Journal:  Stroke       Date:  2002-04       Impact factor: 7.914

5.  Age and National Institutes of Health Stroke Scale Score within 6 hours after onset are accurate predictors of outcome after cerebral ischemia: development and external validation of prognostic models.

Authors:  C Weimar; I R König; K Kraywinkel; A Ziegler; H C Diener
Journal:  Stroke       Date:  2003-12-18       Impact factor: 7.914

6.  Outcome in patients with basilar artery occlusion treated conventionally.

Authors:  W J Schonewille; A Algra; J Serena; C A Molina; L J Kappelle
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-09       Impact factor: 10.154

7.  Outcome of acute stroke patients without visible occlusion on early arteriography.

Authors:  Marcel Arnold; Krassen Nedeltchev; Caspar Brekenfeld; Urs Fischer; Luca Remonda; Gerhard Schroth; Heinrich Mattle
Journal:  Stroke       Date:  2004-04-08       Impact factor: 7.914

8.  Frequency and clinical course of stroke and transient ischemic attack patients with intracranial nonocclusive thrombus on computed tomographic angiography.

Authors:  Volker Puetz; Imanuel Dzialowski; Shelagh B Coutts; Michael D Hill; Andrea Krol; Christine O'Reilly; Mayank Goyal; Andrew M Demchuk
Journal:  Stroke       Date:  2008-11-06       Impact factor: 7.914

9.  Combined intravenous and intra-arterial recanalization for acute ischemic stroke: the Interventional Management of Stroke Study.

Authors: 
Journal:  Stroke       Date:  2004-03-11       Impact factor: 7.914

10.  Predicting functional outcome in acute stroke: comparison of a simple six variable model with other predictive systems and informal clinical prediction.

Authors:  C Counsell; M Dennis; M McDowall
Journal:  J Neurol Neurosurg Psychiatry       Date:  2004-03       Impact factor: 10.154

View more
  107 in total

1.  Emergency and critical care management of acute ischaemic stroke.

Authors:  Stephen A Figueroa; Weidan Zhao; Venkatesh Aiyagari
Journal:  CNS Drugs       Date:  2015-01       Impact factor: 5.749

Review 2.  Critical Care of Brain Reperfusion.

Authors:  Shailesh Male; Chris Nickele; Lucas Elijovich
Journal:  Curr Neurol Neurosci Rep       Date:  2016-03       Impact factor: 5.081

3.  Precision Stroke Animal Models: the Permanent MCAO Model Should Be the Primary Model, Not Transient MCAO.

Authors:  Devin W McBride; John H Zhang
Journal:  Transl Stroke Res       Date:  2017-07-17       Impact factor: 6.829

Review 4.  Endovascular therapy in hyperacute ischaemic stroke: history and current status.

Authors:  Alex M Mortimer; Marcus D Bradley; Shelley A Renowden
Journal:  Interv Neuroradiol       Date:  2013-12-18       Impact factor: 1.610

5.  Repeated Mechanical Thrombectomy in Recurrent Large Vessel Occlusion Acute Ischemic Stroke.

Authors:  Mehdi Bouslama; Diogo C Haussen; Leticia C Rebello; Jonathan A Grossberg; Michael R Frankel; Raul G Nogueira
Journal:  Interv Neurol       Date:  2016-09-09

Review 6.  What is new in stroke imaging and intervention?

Authors:  Philip White; Andrew Nanapragasam
Journal:  Clin Med (Lond)       Date:  2018-04-01       Impact factor: 2.659

Review 7.  Functional outcomes and recanalization rates of stent retrievers in acute ischaemic stroke: A systematic review and meta-analysis.

Authors:  Reuben Grech; Adrian Mizzi; Richard Pullicino; John Thornton; Jonathan Downer
Journal:  Neuroradiol J       Date:  2015-04-30

8.  Mechanical Thrombectomy-Ready Comprehensive Stroke Center Requirements and Endovascular Stroke Systems of Care: Recommendations from the Endovascular Stroke Standards Committee of the Society of Vascular and Interventional Neurology (SVIN).

Authors:  Joey D English; Dileep R Yavagal; Rishi Gupta; Vallabh Janardhan; Osama O Zaidat; Andrew R Xavier; Raul G Nogueira; Jawad F Kirmani; Tudor G Jovin
Journal:  Interv Neurol       Date:  2016-02-19

9.  Evaluation of Patients with High National Institutes of Health Stroke Scale as Thrombectomy Candidates Using the Kentucky Appalachian Stroke Registry.

Authors:  Parneet Grewal; Michael R Dobbs; Keith Pennypacker; Richard J Kryscio; Patrick Kitzman; Marc Wolfe; Kelley Elkins; Gregory J Bix; Justin F Fraser
Journal:  Cerebrovasc Dis       Date:  2019-12-18       Impact factor: 2.762

Review 10.  Endovascular Stroke Therapy.

Authors:  Wade S Smith
Journal:  Neurotherapeutics       Date:  2019-04       Impact factor: 7.620

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.